We have detected that you are using Internet Explorer to visit this website. Internet Explorer is now being phased out by Microsoft. As a result, NHS Digital no longer supports any version of Internet Explorer for our web-based products, as it involves considerable extra effort and expense, which cannot be justified from public funds. Some features on this site will not work. You should use a modern browser such as Edge, Chrome, Firefox, or Safari. If you have difficulty installing or accessing a different browser, contact your IT support team.
National Pulmonary Hypertension Audit - 2013
Audit, Open data- Publication Date:
- 10 Jan 2014
- Geographic Coverage:
- England, Scotland
- Geographical Granularity:
- NHS Trusts, Country, Hospital Trusts
- Date Range:
- Snapshot on 10 Jan 2014
Summary
Pulmonary hypertension is a rare disease which occurs at any age, has many causes, and often shortens life expectancy. In the UK seven hospitals have been designated to diagnose and treat pulmonary hypertension in adults and one hospital for children. The National Audit of Pulmonary Hypertension (NAPH) is a prospective audit of processes and outcomes and has the participation of all eight designated centres. This report of the fourth year brings together the audit data collected from the nationally designated centres (Table 1). It builds on the previous reports. The audit has reviewed the data items and developed and restructured the dataset. The audit report details centre level data for disease targeted therapies. The data presented in this report is for the year from 1 April 2012 to 31 March 2013 and covers all patients seen at the designated centres. This audit includes England, Scotland, Wales, Northern Ireland, the Channel Islands, Gibraltar and the Isle of Man.